In the fast-paced world of pharmaceutical development, securing reliable sources for key intermediates is paramount. For companies involved in the synthesis of advanced therapeutics like Milvexian, understanding the intricacies of sourcing critical components is a strategic advantage. One such vital component is the pharmaceutical intermediate 6-(5-Chloro-2-(4-Chloro-1H-1,2,3-Triazol-1-yl)Phenyl)Pyrimidin-4-ol, identified by its CAS number 1802430-55-2.

Milvexian is a significant antithrombotic agent, recognized for its role in targeting Factor XIa. The efficacy and purity of the final Active Pharmaceutical Ingredient (API) are directly dependent on the quality of the intermediates used in its synthesis. Therefore, when procuring 6-(5-Chloro-2-(4-Chloro-1H-1,2,3-Triazol-1-yl)Phenyl)Pyrimidin-4-ol, buyers must prioritize purity, consistency, and reliable supply from reputable manufacturers.

Key Considerations When Buying Pharmaceutical Intermediates

For procurement managers and R&D scientists, the selection process for pharmaceutical intermediates involves several critical factors:

  • Purity Levels: High purity, typically exceeding 98%, is non-negotiable for pharmaceutical intermediates. Impurities can affect reaction yields, product quality, and potentially lead to regulatory issues.
  • Supplier Reliability: Establishing a strong relationship with a dependable manufacturer is crucial. This includes consistent production capacity, adherence to delivery schedules, and robust quality control measures.
  • Regulatory Compliance: While intermediates may have different regulatory pathways than APIs, manufacturers should still operate under stringent quality management systems, such as ISO certifications, and provide necessary documentation.
  • Technical Specifications: Detailed product specifications, including analytical data (e.g., NMR, HPLC, IR), are essential for verifying the intermediate's identity and quality.

The Role of 6-(5-Chloro-2-(4-Chloro-1H-1,2,3-Triazol-1-yl)Phenyl)Pyrimidin-4-ol

This specific intermediate serves as a foundational building block in the synthesis of Milvexian. Its unique chemical structure, featuring chlorinated phenyl, triazole, and pyrimidinone moieties, is meticulously designed to facilitate the subsequent steps in creating the final drug molecule. As a manufacturer specializing in such complex organic synthesis, we ensure that our production processes yield this intermediate with exceptional purity and structural integrity. We are a dedicated manufacturer and supplier, offering this essential compound for your research and development needs. If you are looking to buy 6-(5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl)pyrimidin-4-ol, consider partnering with us to ensure a seamless procurement process.

Why Partner with a Chinese Manufacturer?

China has emerged as a global hub for chemical synthesis and pharmaceutical intermediate production. By sourcing from a reputable Chinese manufacturer, companies can benefit from:

  • Competitive Pricing: Access to high-quality intermediates at competitive price points, optimizing project budgets.
  • Extensive Manufacturing Capabilities: Access to advanced synthesis techniques and large-scale production facilities.
  • Established Supply Chains: Experienced manufacturers have well-developed logistics networks for efficient global delivery.

When seeking a pharmaceutical intermediate manufacturer in China, due diligence is key. Look for suppliers with transparent quality management, clear technical documentation, and a proven track record in complex organic synthesis. Our company is committed to providing precisely that, ensuring you receive the highest quality CAS 1802430-55-2 supplier for your Milvexian synthesis projects. We understand the market dynamics and can provide you with competitive Milvexian intermediate price information upon inquiry. For those in need of specialized chemical solutions, we also offer custom synthesis pharmaceutical intermediate services to meet unique project requirements.